Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q2

3353.TEDINET S100PCTW
Period2022-03-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥17.0bn2022-03-01 → 2022-08-31Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥16.8bn2021-03-01 → 2021-08-31Cons.Net sales
Operating income¥466m2022-03-01 → 2022-08-31Cons.Operating income
Operating income¥645m2021-03-01 → 2021-08-31Cons.Operating income
Ordinary income¥598m2022-03-01 → 2022-08-31Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥682m2021-03-01 → 2021-08-31Cons.Ordinary income
Profit before tax¥624m2022-03-01 → 2022-08-31Cons.Income before income taxes
Profit before tax¥781m2021-03-01 → 2021-08-31Cons.Income before income taxes
Net income (owners)¥374m2022-03-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥444m2021-03-01 → 2021-08-31Cons.Profit loss attributable to owners of parent
Net income¥386m2022-03-01 → 2022-08-31Cons.Profit loss
Net income¥452m2021-03-01 → 2021-08-31Cons.Profit loss
Total assets¥28.3bnat 2022-08-31Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥30.2bnat 2021-08-31Cons.Total assets (5-year summary)
Total liabilities¥16.1bnat 2022-08-31Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.2bnat 2022-08-31Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥11.6bnat 2021-08-31Cons.Net assets (5-year summary)
Cash and deposits¥7.0bnat 2022-08-31Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
Cash & equivalents¥6.8bnat 2022-08-31Cons.Cash and cash equivalents
Cash & equivalents¥7.8bnat 2022-02-28Cons.Cash and cash equivalents
Cash & equivalents¥8.4bnat 2021-08-31Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2021-02-28dCons.Cash and cash equivalents
Operating cash flow¥496m2022-03-01 → 2022-08-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-03-01 → 2022-02-28Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥334m2021-03-01 → 2021-08-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥291m2022-03-01 → 2022-08-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥216m2021-03-01 → 2022-02-28Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥47m2021-03-01 → 2021-08-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.2bn2022-03-01 → 2022-08-31Cons.Net cash provided by used in financing activities
Financing cash flow¥65m2021-03-01 → 2022-02-28Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.3bn2021-03-01 → 2021-08-31Cons.Net cash provided by used in financing activities
EPS (basic)¥99.652022-03-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.262022-06-01 → 2022-08-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥118.222021-03-01 → 2021-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.132021-06-01 → 2021-08-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio41.2%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio36.6%at 2021-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-08-31−¥385m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-08-31¥736m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-08-31¥35m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-08-31¥1.9bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-08-31¥1.4bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥495m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-08-31¥20m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-08-31¥95m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-08-31¥94m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥876,000
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-08-31¥61m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-08-31¥17.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-08-31¥17.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-08-31¥497m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-08-31¥851m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-08-31−¥545m
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-08-31−¥545m
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-08-31−¥347m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2021-08-31¥11.3bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2021-08-31¥11.3bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2021-08-31¥731m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2021-03-01 → 2021-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2021-03-01 → 2021-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2021-03-01 → 2021-08-31¥146m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2021-08-31¥2.0bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2021-08-31¥1.4bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥543m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2021-08-31¥50m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2021-03-01 → 2021-08-31¥117m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2021-03-01 → 2021-08-31¥116m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥960,000
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2021-03-01 → 2021-08-31¥65m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-08-31¥17.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-08-31¥16.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-08-31¥545m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-08-31¥992m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 501
ItemContextValueUnit
Other nclPrior1YearInstant408878000JPY
Other nclCurrentQuarterInstant341572000JPY
Noncurrent liabilitiesPrior1YearInstant8750301000JPY
Noncurrent liabilitiesCurrentQuarterInstant7869029000JPY
LiabilitiesPrior1YearInstant17166398000JPY
LiabilitiesCurrentQuarterInstant16100560000JPY
Capital stockPrior1YearInstant917000000JPY
Capital stockCurrentQuarterInstant917000000JPY
Capital surplusPrior1YearInstant1080381000JPY
Capital surplusCurrentQuarterInstant1081272000JPY
Retained earningsPrior1YearInstant9948627000JPY
Retained earningsCurrentQuarterInstant10247847000JPY
Treasury stockPrior1YearInstant-541555000JPY
Treasury stockCurrentQuarterInstant-539830000JPY
Shareholders equityPrior1YearInstant11404452000JPY
Shareholders equityCurrentQuarterInstant11706288000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-20093000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-54615000JPY
Remeasurements of defined benefit plansPrior1YearInstant-1295000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-647000JPY
Valuation and translation adjustmentsPrior1YearInstant-21389000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-55263000JPY
Non controlling interestsPrior1YearInstant544795000JPY
Non controlling interestsCurrentQuarterInstant556577000JPY
Net assetsPrior1YearInstant11927858000JPY
Net assetsCurrentQuarterInstant12207602000JPY
Liabilities and net assetsPrior1YearInstant29094256000JPY
Liabilities and net assetsCurrentQuarterInstant28308163000JPY
Net salesPrior1YTDDuration16812994000JPY
Net salesCurrentYTDDuration16978990000JPY
Cost of salesPrior1YTDDuration14995783000JPY
Cost of salesCurrentYTDDuration15340148000JPY
Gross profitPrior1YTDDuration1817210000JPY
Gross profitCurrentYTDDuration1638841000JPY
Selling general and administrative expensesPrior1YTDDuration1172106000JPY
Selling general and administrative expensesCurrentYTDDuration1173196000JPY
Operating incomePrior1YTDDuration645104000JPY
Operating incomeCurrentYTDDuration465645000JPY
Interest income noiPrior1YTDDuration724000JPY
Interest income noiCurrentYTDDuration678000JPY
Dividends income noiPrior1YTDDuration16678000JPY
Dividends income noiCurrentYTDDuration20422000JPY
Subsidy income noi bountyPrior1YTDDuration33173000JPY
Subsidy income noi bountyCurrentYTDDuration67125000JPY
Gain on reversal of advance received noiPrior1YTDDuration－JPY
Gain on reversal of advance received noiCurrentYTDDuration48528000JPY
Other noiPrior1YTDDuration18230000JPY
Other noiCurrentYTDDuration24283000JPY
Non operating incomePrior1YTDDuration68806000JPY
Non operating incomeCurrentYTDDuration161038000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-08-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-08-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-08-31pass
statement vs summary · operating cash flowconsolidated 2021-03-01/2021-08-31pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2022-08-31pass
statement vs summary · revenueconsolidated 2021-03-01/2021-08-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-08-31pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-08-31pass